ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon.
Background References
1. Liu L. et al. 2022.The splicing factor RBM17 drives leukemic stem cell maintenance by evading nonsense-mediated decay of pro-leukemic factors. Nat Commun. 13(1):3833.
2. Chen Z.H. et al. 2019. Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer. J Exp Clin Cancer Res.38(1):196.
Western blot analysis of eIF4A2 on different lysates with Rabbit anti-eIF4A2 antibody (HA721747) at 1/1,000 dilution.
Lane 1: HepG2 cell lysate Lane 2: HeLa cell lysate Lane 3: PC-3M cell lysate Lane 4: 293T cell lysate Lane 5: MCF7 cell lysate Lane 6: NIH/3T3 cell lysate Lane 7: C2C12 cell lysate Lane 8: PC-12 cell lysate Lane 9: COS-1 cell lysate Lane 10: Human brain tissue lysate Lane 11: Mouse testis tissue lysate Lane 12: Rat testis tissue lysate
Lysates/proteins at 30 µg/Lane.
Predicted band size: 46 kDa Observed band size: 46 kDa
Exposure time: 24 seconds;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA721747) at 1/1,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"